Use of psychotropic medications by US cancer survivors

Psycho-Oncology

Volumn 21, Issue 11, 2012, Pages 1237-1243

  Punekar, Rajeshwari S ^a   Short, Pamela Farley ^b   Moran, John R ^b  

^a Center for Applied Health Research   (United States)

^b PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

cancer; oncology; psychotropic medicines; survivorship; utilization

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; CENTRAL STIMULANT AGENT; HYPNOTIC SEDATIVE AGENT; PSYCHOTROPIC AGENT;

ADULT; AGED; ARTICLE; CANCER SURVIVOR; DRUG USE; FEMALE; GROUPS BY AGE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRESCRIPTION; SEX DIFFERENCE; UNITED STATES;

CANCER; ONCOLOGY; PSYCHOTROPIC MEDICINES; SURVIVORSHIP; UTILIZATION;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; DRUG PRESCRIPTIONS; DRUG UTILIZATION; FEMALE; HEALTH CARE SURVEYS; HUMANS; INTERVIEWS AS TOPIC; MALE; MIDDLE AGED; NEOPLASMS; PROPENSITY SCORE; PSYCHOTROPIC DRUGS; QUESTIONNAIRES; SEX FACTORS; SURVIVORS; UNITED STATES;

EID: 84868521609     PISSN: 10579249     EISSN: 10991611     Source Type: Journal    
DOI: 10.1002/pon.2039     Document Type: Article

References (30)

1. Portenoy RK, Itri LM,. Cancer-related fatigue: guidelines for evaluation and management. Oncologist 1999; 4 (1): 1-10.
2. Bruera E, Neumann C,. The uses of psychotropics in symptom management in advanced cancer. Psycho-Oncology 1998; 7 (4): 346-358.
3. Jordan K., Chemotherapy-induced nausea and vomiting: current and new standards in the antiemetic prophylaxis and treatment. Eur J Cancer 2005: 41 (2): 199.
4. Carr D, Goudas L, Lawrence D, et al,. Management of Cancer Symptoms: Pain, Depression, and Fatigue. In AHRQ Publication No. 02-E032. Agency for Healthcare Research and Quality: Rockville, MD, 2002; 1-504.
5. Derogatis L, Feldstein M, Melisaratos N, et al,. A survey of psychotropic drug prescriptions in an oncology population. Cancer 1979; 44 (5): 1919-1929.
6. Goldberg R, Mor V,. A survey of psychotropic use in terminal cancer patients. Psychosomatics 1985; 26 (9): 745-751.
7. Stiefel F, Kornblith A, Holland J,. Changes in the prescription patterns of psychotropic drugs for cancer patients during a 10-year period. Cancer 1990; 65 (4): 1048-1053.
8. Cullivan R, Crown J, Walsh N,. The use of psychotropic medication in patients referred to a psycho-oncology service. Psycho-Oncology 1998; 7 (4): 301-306.
9. SEER. SEER Cancer Statistics Review, 1975-2007, 2010. (Available from: http://seer.cancer.gov/csr/1975-2007/)
10. Hewitt M, Greenfield S,. From Cancer Patient to Cancer Survivor: Lost in Transition. Institute of Medicine: Washington, D.C., 2005.
11. IOM. In Cancer Care for the Whole Patient: Meeting Psychosocial Health Needs, Edler N, Page A, (eds). Institute of Medicine: Washington, D.C., 2008.
12. NCHS. 2004 National Health Interview Survey (NHIS): NHIS Survey Description. Centers for Disease Control and Prevention and U.S. Department of Health and Human Services: Hyattsville, MD, 2004.
13. AHRQ. MEPS HC-105:2006 Full Year Consolidated Data File. 2006. http://www.linkedin.com/in/rpunekar [Accessed February 2009].
14. AHRQ. MEPS HC-0102A:2006 Prescribed Medicines: Data Documentation. U.S. Center for Financing, Access, and Cost Trends: Rockville, MD, 2006.
15. AHRQ. MEPS HC-104:2006 Medical Conditions, 2006. (Available from: http://www.meps.ahrq.gov/mepsweb/data-stats/download-data/pufs/h104/h104doc.pdf)
16. ACS. Cancer Facts and Figures, 2005. American Cancer Society: Atlanta, 2005.
17. Harder VS, Stuart EA, Anthony JC,. Propensity score techniques and the assessment of measured covariate balance to test causal associations in psychological research. Psychol Methods 2010; 15 (3): 234-249.
18. D'Agostino RB,. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med 1998; 17: 2265-2281.
19. Heckman JJ, Ichimura H, Todd PE,. Matching as an econometric evaluation estimator: evidence from evaluating a job training program. Rev Econ Stud 1997; 64 (4): 605-654.
20. Frolich M., Finite-sample properties of propensity-score matching and weighting estimators. Rev Econ Stat 2004; 86 (1): 77-90.
21. Abadie A, Imbens G,. On the failure of the bootstrap for matching estimators. Econometrica 2008; 76 (6): 1537-1557.
22. Leuven ESB,. PSMATCH2: Stata module to perform full Mahalanobis and propensity score matching, common support graphing, and covariate imbalance testing, 2003. (Available from: http://ideas.repec.org/c/boc/bocode/s432001. html/ Version 3.0.0.)
23. Bradley S, Rose S, Lutgendorf S, Costanzo E, Anderson B,. Quality of life and mental health in cervical and endometrial cancer survivors. Gynecol Oncol 2006; 100 (3): 479-486.
24. Fleer J, Hoekstra HJ, Sleijfer DT, Tuinman MA, Klip EC, Hoekstra-Weebers JEHM,. Quality of life of testicular cancer survivors and the relationship with socio-demographics, cancer-related variables, and life events. Support Care Cancer 2006; 14 (3): 251-259.
25. Peuckmann V, Ekholm O, Rasmussen NK, et al,. Health-related quality of life in long-term breast cancer survivors: nationwide survey in Denmark. Breast Cancer Res Treat 2007; 104 (1): 39-46.
26. Bardwell W, Major JM, Rock CL, et al,. Health-related quality of life in women previously treated for early-stage breast cancer. Psycho-Oncology 2004; 13 (9): 595-604.
27. Keating N, Nørredam M, Landrum MB, Huskamp HA, Meara E,. Physical and mental health status of older long-term cancer survivors. J Am Geriatr Soc 2005; 53 (12): 2145-2152.
28. Mols F, van de Poll-Franse LV, Vingerhoets AJJM, et al,. Long-term quality of life among Dutch prostate cancer survivors: results of a population-based study. Cancer 2006; 107 (9): 2186-2196.
29. Bower J, Meyerowitz BE, Bernaards CA, Rowland JH, Ganz PA, Desmond KA,. Perceptions of positive meaning and vulnerability following breast cancer: predictors and outcomes among long-term breast cancer survivors. Ann Behav Med 2005; 29 (3): 236-245.
30. Thornton AA,. Perceiving benefits in the cancer experience. J Clin Psychol Med Settings 2002; 9 (2): 153-165.